Effect of Platelet Activating Factor on the Human Nasal Mucosa
- 1 February 1984
- Vol. 39 (2) , 141-145
- https://doi.org/10.1111/j.1398-9995.1984.tb01946.x
Abstract
To determine the effect of PAF[platelet activating factor]-acether on the vascular bed in the human nose, 11 healthy volunteers were studied. Rhinomanometry was performed to determine the effect on the capacitance vessels, and the 133Xe wash-out method enabled determination of the mucosal blood flow, regulated mainly by the resistance vessels. These measurements were made before and after topical administration of PAF-acether in 3 different doses: 0.26, 2.6 and 26 .mu.g/nostril. Evidently, PAF-acether induces a dose-dependent vasoconstriction of the capacitance vessels and a reduction in mucosal blood flow. That PAF-acether should be a principal mediator in the allergic reaction in the human nose is not supported by these findings.Keywords
This publication has 4 references indexed in Scilit:
- Budesonide and Nasal Allergen Challenge Testing in ManAllergy, 1982
- Platelet-activating factor (PAF-acether): Present statusInflammation Research, 1981
- Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivativesEuropean Journal of Pharmacology, 1980
- Allergic Rhinitis and Intravascular Aggregation of Blood CellsActa Oto-Laryngologica, 1964